Best Michaelcallaghan Podcasts (2025)

show episodes

1
MedEdTalks - Hematology

Vindico Medical Education

Unsubscribe

5y ago5y ago

Unsubscribe

Monthly

MedEdTalks Hematology is an accredited educational podcast for providers to learn more about treating patients with Hematology diseases/disorders. Discover all content and topics by visiting mededtalks.com.

show series

1
Harnessing Shared Decision-making in Patients With Hemophilia A With Regina Butler, RN-BC and Courtney Thornburg, MD 13:10

5y ago13:10

13:10

In this podcast, expert clinicians review strategies to engage patients with hemophilia A in their own care to improve overall patient satisfaction.By Regina Butler

1
Communicating With Patients for Optimized Hemophilia A Care With Regina Butler, RN-BC and Patient Advocate, Charles Felthaus 13:39

5y ago13:39

13:39

In this podcast, a clinician and patient discuss his experience with hemophilia A, addressing patient concerns regarding this condition, its management, and preferred communication methods.By Regina Butler

1
New Treatment Options to Overcome Challenges in Hemophilia A Management With Regina Butler, RN-BC and Michael Callaghan, MD 14:08

5y ago14:08

14:08

In this podcast, expert clinicians discuss recent and emerging treatment options with the potential to benefit patients with and without inhibitors.By Regina Butler

1
V:\Activity\Hematology_Oncology\2020\2020 Genentech Hemophilia A Podcast Series_K255\2020 Genentech Hemophilia A Podcast Series Web-K255\Deliverables\Final Audio Files\K255 WITHOUT INTROS 15:00

5y ago15:00

15:00

In this podcast, expert clinicians discuss historical challenges in hemophilia A care and how recent therapeutic advancements help to overcome these limitations.By Regina Butler

1
Hemophilia A: Incorporating New Therapeutic Strategies to Address Historical Treatment Challenges 1:07

5y ago1:07

1:07

Hemophilia A is an X-linked recessive disease primarily affecting males. An estimated 20,000 individuals in the United States have the disease. Conventional standard of care for patients with severe disease is factor VIII administration given prophylactically or to treat bleeding episodes. Almost 30% of patients treated with factor VIII develop neu…